Victoria P. Werth, MD, discusses how litifilimab’s 52-week AMETHYST findings inform treatment expectations and timely reassessment of persistent cutaneous lupus symptoms.
|Articles|September 1, 2021
Pharmacy Clinical Pearl of the Day: Atopic Dermatitis
Author(s)Saro Arakelians, PharmD
Atopic dermatitis treatments include creams for itching, calcineurin inhibitors such as Protopic and Elidel, as well as biologics such as Dupixent.
Advertisement
Clinical Pearl of the Day: Atopic Dermatitis
- Eczema: itchy and red skin
Explanation:
- Atopic dermatitis (eczema) is a condition that makes your skin red and itchy.
- It is common in children but can occur at any age.
- When chronic, it tends to flare up periodically.
- Symptoms include dry skin, itching, red to brownish patches especially on the hands, feet, ankles, wrist, chest, elbows, face, and scalp.
- Treatment includes creams for itching, calcineurin inhibitors such as Protopic and Elidel, as well as biologics such as Dupixent (dupilumab).
Reference:
Advertisement
Related to this article
In an interview with Pharmacy Times, Victoria P. Werth, MD, professor of dermatology at the University of Pennsylvania and chief of dermatology at the Philadelphia VA Medical Center, discusses why meaningful improvement extends beyond skin clearance and how response timing affects patients with difficult-to-control disease.
Experts on Lp(a) testing, statin myths, cognitive safety, and the 2025-2030 Dietary Guidelines share counseling points from the National Lipid Association's Fall Clinical Lipid Update meeting.
At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.
Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.
Emergency and ICU pharmacists would be most likely to see pneumonic plague. An expert reviews first-line agents, alternatives, and postexposure prophylaxis.
A former residency program director unpacks why this debate keeps resurfacing, and why some reasons people give for skipping residency may not hold up the way they think they do.
Eric Lawitz, MD, explains how pharmacists can discuss liver risk with patients with obesity and why a FIB-4 score from routine blood work is a good first step.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Preparing Pharmacists for Psychedelic Medicine
2
Pneumonic Plague: What Pharmacists Need to Know About Treatment
3
Beyond Skin Clearance: What Litifilimab Could Mean for Cutaneous Lupus Care
4
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
5